Live Donor Liver Transplantation in the United States: Impact of Share 35 on Live Donor Utilization

od Braun, Hillary J., Dodge, Jennifer L., Grab, Joshua D., Glencer, Alexa C., Schwab, Marisa E., Stock, Peter G., Hirose, Ryutaro, Roberts, John P., Ascher, Nancy L.
Wydane w Transplantation (2021)

Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection

od Glencer, Alexa C., Wong, Jasmine M., Hylton, Nola M., Krings, Gregor, McCune, Emma, Rothschild, Harriet T., Loveday, Tristan A., Alvarado, Michael D., Esserman, Laura J., Campbell, Michael J.
Wydane w NPJ Breast Cancer (2021)

A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer

od Rugo, Hope S., Jo Chien, A., Franco, Sandra X., Stopeck, Alison T., Glencer, Alexa, Lahiri, Soumi, Arbushites, Michael C., Scott, Janet, Park, John W., Hudis, Clifford, Nulsen, Ben, Dickler, Maura N.
Wydane 2011

Retransplantation After Living Donor Liver Transplantation: Data from the Adult to Adult Living Donor Liver Transplantation Study (A2ALL)

od Braun, Hillary J., Grab, Joshua D., Dodge, Jennifer L., Syed, Shareef M., Roll, Garrett R., Schwab, Marisa P., Liu, Iris H., Glencer, Alexa C., Freise, Chris E., Roberts, John P., Ascher, Nancy L.
Wydane w Transplantation (2021)